Syndax Pharmaceuticals (SNDX) – Analyst Ratings
-
Scotiabank Downgrades Syndax Pharmaceuticals (SNDX) to Sector Perform
-
Mizuho Securities Starts Syndax Pharmaceuticals (SNDX) at Buy, 'Two Near-Term Commercial Opportunities With Upside Drives Our Buy'
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to SNDX Stock Lookup